Baltimore, Maryland
The David Goldfarb, MD Professor of Surgery
The Johns Hopkins University School of Medicine
Chief and Regional Director of Vascular Surgery and Endovascular Therapy
The Johns Hopkins Hospital and Johns Hopkins Medicine
SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
Session Moderator
SESSION-16: UPDATE ON OPEN VASCULAR SURGICAL PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS (FOR IMPORTANT RELATED TALKS SEE SESSION 16 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHSYMPOSIUM.ORG)
Presenter
SESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF THE ASCENDING AORTA, AORTIC ARCH, AORTIC DISSECTIONS, REPORTING STANDARDS AND CLASSIFICATION SYSTEMS, STABILISE, GUIDELINES AND MORE
High Risk Features Of TEVAR For TBAD: Did The AHA Guidelines Get Them Right: TEVAR Outcomes For TBAD Are Worse Than For Degenerative Aneurysms
9:56 AM - 10:01 AM
Presenter
SESSION 16: UPDATE ON OPEN VASCULAR SURGICAL PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS (FOR IMPORTANT RELATED TALKS SEE SESSION 16 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHSYMPOSIUM.ORG)
Strategies And Technical Challenges In The Open Treatment Of Large TAAAs In Patients With Connective Tissue Disorders
4:48 PM - 4:53 PM
Wednesday, November 20, 2024
Session Moderator
SESSION-44: MORE NEW DEVELOPMENTS IN AAAS: WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS): HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR; OTHER RELATED AAA TOPICS
Presenter
SESSION 44: MORE NEW DEVELOPMENTS IN AAAS: WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS): HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR; OTHER RELATED AAA TOPICS
In Patients With AAAs From Genetic Aortopathy (Heritable Aortic Disease): Is Active Exercise Beneficial Or Harmful
2:12 PM - 2:17 PM
Friday, November 22, 2024
Presenter
SESSION 79: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
How To Use Motor Evoked Potentials (MEPs) To Decrease The Incidence Of SCI After Open And Endo TAAA Repairs: What Else Is Important
7:04 AM - 7:09 AM
Presenter
SESSION 93: BEST ANTIPLATELET REGIMENS UPDATE ON RARE VASCULAR DISEASES; NEW DEVELOPMENTS IN ANTIPLATELET AND ANTICOAGULATION REGIMENS AND MEDICAL AND DRUG TREATMENTS
How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well
2:54 PM - 2:59 PM
 
previous next